Beijing Health Guard’s Trial Pauses Add To China HPV Vaccine Makers’ Distress

Beijing Health Guard's three Phase III clinical trials of two HPV vaccine candidates for the prevention of viral infections had been paused. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D